Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [815]
News [1667]
Articles [253]
Editorials [5]
Conferences [138]
elearning [32]
Sunitinib with or without surgery for metastatic renal cell carcinoma
Prof Arnaud Mejean - Paris Descartes University, Paris, France
Sunitinib with or without surgery for metastatic renal cell carcinoma ( Prof Arnaud Mejean - Paris Descartes University, Paris, France )
3 Jun 2018
Comment: Kidney surgery may be unneeded in many intermediate-risk patients
Dr Sumanta Pal & Prof Richard Schilsky
Comment: Kidney surgery may be unneeded in many intermediate-risk patients ( Dr Sumanta Pal & Prof Richard Schilsky )
3 Jun 2018
Kidney surgery may be unneeded in many intermediate-risk patients
Prof Arnaud Mejean - Paris Descartes University, Paris, France
Kidney surgery may be unneeded in many intermediate-risk patients ( Prof Arnaud Mejean - Paris Descartes University, Paris, France )
3 Jun 2018
Editor’s Choice for May 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor’s Choice for May 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
21 May 2018
Thrombosis risk and management in multiple myeloma
Dr Joseph Mikhael - Chief Medical Officer of the International Myeloma...
Thrombosis risk and management in multiple myeloma ( Dr Joseph Mikhael - Chief Medical Officer of the International Myeloma Foundation )
2 May 2018
Neoadjuvant nivolumab for resectable lung cancer
Dr Drew Pardoll - Johns Hopkins Medicine, Baltimore, USA
Neoadjuvant nivolumab for resectable lung cancer ( Dr Drew Pardoll - Johns Hopkins Medicine, Baltimore, USA )
25 Apr 2018
Response and safety profile of neoadjuvant nivolumab for resectable lung cancer
Dr Drew Pardoll - Johns Hopkins Medicine, Baltimore, USA
Response and safety profile of neoadjuvant nivolumab for resectable lung cancer ( Dr Drew Pardoll - Johns Hopkins Medicine, Baltimore, USA )
25 Apr 2018
Management of marker negative stage II testicular cancer
Dr Christian Kollmannsberger - University of British Columbia, Vancouver, Canada
Management of marker negative stage II testicular cancer ( Dr Christian Kollmannsberger - University of British Columbia, Vancouver, Canada )
16 Mar 2018
Editor's Choice for February 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for February 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
26 Feb 2018
Comment: Urothelial cancer research from ASCO GU 2018
Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA
Comment: Urothelial cancer research from ASCO GU 2018 ( Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA )
9 Feb 2018
Guidelines and genomic factors for endometrial cancer
Dr Maia Dzhugashvili - GenesisCare, Spain
Guidelines and genomic factors for endometrial cancer ( Dr Maia Dzhugashvili - GenesisCare, Spain )
26 Jan 2018
Options for breast reconstruction for younger breast cancer patients
Prof Marie Wickman - Karolinska University Hospital, Solna, Sweden
Options for breast reconstruction for younger breast cancer patients ( Prof Marie Wickman - Karolinska University Hospital, Solna, Sweden )
26 Jan 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation